Details
| Stereochemistry | ABSOLUTE |
| Molecular Formula | C26H22ClF3N2O6S |
| Molecular Weight | 582.976 |
| Optical Activity | ( + ) |
| Defined Stereocenters | 1 / 1 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
COC1=CC(N[C@H](C(=O)C2=CNC3=C2C=C(OC(F)(F)F)C=C3)C4=CC=C(Cl)C=C4OC)=CC(=C1)S(C)(=O)=O
InChI
InChIKey=QNOPDDHSGQQLCV-DEOSSOPVSA-N
InChI=1S/C26H22ClF3N2O6S/c1-36-17-9-15(10-18(11-17)39(3,34)35)32-24(19-6-4-14(27)8-23(19)37-2)25(33)21-13-31-22-7-5-16(12-20(21)22)38-26(28,29)30/h4-13,24,31-32H,1-3H3/t24-/m0/s1
| Molecular Formula | C26H22ClF3N2O6S |
| Molecular Weight | 582.976 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ABSOLUTE |
| Additional Stereochemistry | No |
| Defined Stereocenters | 1 / 1 |
| E/Z Centers | 0 |
| Optical Activity | UNSPECIFIED |
Approval Year
| Substance Class |
Chemical
Created
by
admin
on
Edited
Wed Apr 02 03:57:57 GMT 2025
by
admin
on
Wed Apr 02 03:57:57 GMT 2025
|
| Record UNII |
5EJO0RJF9O
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Official Name | English | ||
|
Preferred Name | English | ||
|
Code | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
FDA ORPHAN DRUG |
618217
Created by
admin on Wed Apr 02 03:57:57 GMT 2025 , Edited by admin on Wed Apr 02 03:57:57 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
5EJO0RJF9O
Created by
admin on Wed Apr 02 03:57:57 GMT 2025 , Edited by admin on Wed Apr 02 03:57:57 GMT 2025
|
PRIMARY | |||
|
C203178
Created by
admin on Wed Apr 02 03:57:57 GMT 2025 , Edited by admin on Wed Apr 02 03:57:57 GMT 2025
|
PRIMARY | |||
|
2043343-93-5
Created by
admin on Wed Apr 02 03:57:57 GMT 2025 , Edited by admin on Wed Apr 02 03:57:57 GMT 2025
|
NON-SPECIFIC STEREOCHEMISTRY | |||
|
MN-164
Created by
admin on Wed Apr 02 03:57:57 GMT 2025 , Edited by admin on Wed Apr 02 03:57:57 GMT 2025
|
PRIMARY | |||
|
133083036
Created by
admin on Wed Apr 02 03:57:57 GMT 2025 , Edited by admin on Wed Apr 02 03:57:57 GMT 2025
|
PRIMARY | |||
|
12760
Created by
admin on Wed Apr 02 03:57:57 GMT 2025 , Edited by admin on Wed Apr 02 03:57:57 GMT 2025
|
PRIMARY | |||
|
2043343-94-6
Created by
admin on Wed Apr 02 03:57:57 GMT 2025 , Edited by admin on Wed Apr 02 03:57:57 GMT 2025
|
PRIMARY | |||
|
300000035980
Created by
admin on Wed Apr 02 03:57:57 GMT 2025 , Edited by admin on Wed Apr 02 03:57:57 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
TARGET ORGANISM->INHIBITOR |
High potency
|
||
|
TARGET ORGANISM->INHIBITOR |
In the presence of 50% human serum.
EC50
|
||
|
TARGET ORGANISM->INHIBITOR |
EC50
|
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |
inhibitor of dengue virus (DENV) targeting DENV nonstructural protein (NS) 4B.
|